ثنائي هيدروكودايين

Dihydrocodeine is a semi-synthetic morphinan opioid analgesic prescribed for pain, or as an antitussive (either alone or compounded with paracetamol or aspirin). It was developed in Germany in 1908 and first marketed in 1911.

Classification

Chemical: Medicine
Chemical: Morphinan
Chemical: Opioid
Psychoactive: Depressant
Tag: substituted morphinan

Effects

Sedation
Motor Impairment
Respiratory Depression
Constipation
Pupil Constriction
Itchiness
Reduced Anxiety
Euphoria
Anxiety Suppression
Mood Lift
Cognitive Euphoria
Dizziness
Dulled Perception
Increased Music Appreciation
Internal Hallucination
Cognitive Dysphoria
Decreased Libido
Sound Amplification

Routes of Administration

Oral

Dosage

Threshold: 20 mg
Heavy: 200 mg
Common: 100-150 mg
Light: 50-100 mg
Strong: 150-200 mg

Duration

No data available for this section yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

psychonautwiki.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu